help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RELLO, J.
Right arrow Articles by VALLES, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RELLO, J.
Right arrow Articles by VALLES, J.

Am. J. Respir. Crit. Care Med., Volume 156, Number 1, July 1997, 196-200

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

JORDI RELLO, MIGUEL GALLEGO, DOLORS MARISCAL, ROSARIO SOÑORA, and JORDI VALLES

Intensive Care, Respiratory and Microbiology Departments, Hospital de Sabadell, Sabadell, Barcelona, Spain

The use of microbiologic investigations in routine clinical practice, their value in guiding antibiotic prescription, and their influence on outcome were prospectively studied in 113 consecutive adults who developed ventilator-associated pneumonia (VAP). Blood cultures were performed in 78.7% of cases, protected specimen brushing in 95.5%, and bronchoalveolar lavage in only 45.1%. No causative agent was identified in 13 episodes (11.5%), and results of microbial tests directed a change in therapy in 43 (38.0%). Bronchoscopic results revealed inadequate initial selection of antibiotic therapy in 27 cases (23.9%) and led to a change in antibiotic treatment. Inadequate initial selection was still associated with a significantly greater increase in related mortality than adequate initial therapy (37.0% versus 15.4%, p < 0.05), although the change in therapy permitted clinical resolution in 17 (62.9%) of these 27 episodes, and 10 patients were discharged alive. Bronchoscopic results also permitted the reduction of the antibiotic spectrum in seven episodes (6.1%). This study suggests that in patients with VAP, bronchoscopic results are frequently associated with changes in antibiotic therapy. Nevertheless, our findings also emphasize the critical importance of an appropriate early antibiotic therapy.




This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
M. B. Rosbolt, E. S. Sterling, and B. G. Fahy
The Utility of the Clinical Pulmonary Infection Score
J Intensive Care Med, January 1, 2009; 24(1): 26 - 34.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
K. Yang, H. Zhuo, B J. Guglielmo, and J. Wiener-Kronish
Multidrug-Resistant Pseudomonas aeruginosa Ventilator-Associated Pneumonia: The Role of Endotracheal Aspirate Surveillance Cultures
Ann. Pharmacother., January 1, 2009; 43(1): 28 - 35.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. G. Wunderink, M. H. Mendelson, M. S. Somero, T. C. Fabian, A. K. May, H. Bhattacharyya, K. V. Leeper Jr., and J. S. Solomkin
Early Microbiological Response to Linezolid vs Vancomycin in Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Chest, December 1, 2008; 134(6): 1200 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. P. MacGowan and on behalf of the BSAC Working Parties on Resistanc
Clinical implications of antimicrobial resistance for therapy
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii105 - ii114.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al.
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother., July 1, 2008; 62(1): 5 - 34.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Vidaur, K. Planas, R. Sierra, G. Dimopoulos, A. Ramirez, T. Lisboa, and J. Rello
Ventilator-Associated Pneumonia: Impact of Organisms on Clinical Resolution and Medical Resources Utilization
Chest, March 1, 2008; 133(3): 625 - 632.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Garnacho-Montero, C. Ortiz-Leyba, I. Herrera-Melero, T. Aldabo-Pallas, A. Cayuela-Dominguez, J. A. Marquez-Vacaro, J. Carbajal-Guerrero, and J. L. Garcia-Garmendia
Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study
J. Antimicrob. Chemother., February 1, 2008; 61(2): 436 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. T. Micek, K. E. Kollef, R. M. Reichley, N. Roubinian, and M. H. Kollef
Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience
Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3568 - 3573.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. D. Parkins, D. M. Sabuda, S. Elsayed, and K. B. Laupland
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
J. Antimicrob. Chemother., September 1, 2007; 60(3): 613 - 618.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
J. Rello
Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
Eur. Respir. Rev., August 1, 2007; 16(103): 33 - 39.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. I. Siempos, K. Z. Vardakas, K. G. Manta, and M. E. Falagas
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Eur. Respir. J., March 1, 2007; 29(3): 548 - 560.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. K. Scarsi, J. M. Feinglass, M. H. Scheetz, M. J. Postelnick, M. K. Bolon, and G. A. Noskin
Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.
Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3355 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Rello and J. Mallol
Optimal Therapy for Methicillin-Resistant Staphylococcus aureus Pneumonia: What Is the Best Dosing Regimen?
Chest, October 1, 2006; 130(4): 938 - 940.
[Full Text] [PDF]

Home page
 ChestHome page
C. Clec'h, F. Jaureguy, L. Hamza, P. Karoubi, J.-P. Fosse, A. Hamdi, F. Vincent, F. Gonzalez, and Y. Cohen
Agreement Between Quantitative Cultures of Postintubation Tracheal Aspiration and Plugged Telescoping Catheter, Protected Specimen Brush, or BAL for the Diagnosis of Nosocomial Pneumonia.
Chest, October 1, 2006; 130(4): 956 - 961.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. R. Beardsley, J. C. Williamson, J. W. Johnson, C. A. Ohl, T. B. Karchmer, and D. L. Bowton
Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia.
Chest, September 1, 2006; 130(3): 787 - 793.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
I. Porzecanski and D. L. Bowton
Diagnosis and treatment of ventilator-associated pneumonia.
Chest, August 1, 2006; 130(2): 597 - 604.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
K. A. Davis
Ventilator-Associated Pneumonia: A Review
J Intensive Care Med, July 1, 2006; 21(4): 211 - 226.
[Abstract] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. Sandiumenge, E. Diaz, A. Rodriguez, L. Vidaur, L. Canadell, M. Olona, M. Rue, and J. Rello
Impact of diversity of antibiotic use on the development of antimicrobial resistance
J. Antimicrob. Chemother., June 1, 2006; 57(6): 1197 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. H. Kollef, L. E. Morrow, M. S. Niederman, K. V. Leeper, A. Anzueto, L. Benz-Scott, and F. J. Rodino
Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia
Chest, May 1, 2006; 129(5): 1210 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. H. Kollef, A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu, and R. S. Johannes
Epidemiology and Outcomes of Health-care-Associated Pneumonia: Results From a Large US Database of Culture-Positive Pneumonia
Chest, December 1, 2005; 128(6): 3854 - 3862.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. S. Burgess and C. R. Frei
Comparison of {beta}-lactam regimens for the treatment of Gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics
J. Antimicrob. Chemother., November 1, 2005; 56(5): 893 - 898.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Morrell, V. J. Fraser, and M. H. Kollef
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3640 - 3645.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
D. L. Green
Selection of an Empiric Antibiotic Regimen for Hospital-Acquired Pneumonia Using a Unit and Culture-Type Specific Antibiogram
J Intensive Care Med, September 1, 2005; 20(5): 296 - 301.
[Abstract] [PDF]

Home page
 ChestHome page
C. A. DeRyke, T. P. Lodise Jr., M. J. Rybak, and P. S. McKinnon
Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia
Chest, September 1, 2005; 128(3): 1414 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Brun-Buisson, M. Fartoukh, E. Lechapt, S. Honore, J.-R. Zahar, C. Cerf, and B. Maitre
Contribution of Blinded, Protected Quantitative Specimens to the Diagnostic and Therapeutic Management of Ventilator-Associated Pneumonia
Chest, August 1, 2005; 128(2): 533 - 544.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
W. A. Krueger, J. Bulitta, M. Kinzig-Schippers, C. Landersdorfer, U. Holzgrabe, K. G. Naber, G. L. Drusano, and F. Sorgel
Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers
Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1881 - 1889.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. T. Micek, A. E. Lloyd, D. J. Ritchie, R. M. Reichley, V. J. Fraser, and M. H. Kollef
Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1306 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Nopmaneejumruslers and C. K.N. Chan
Is There a Role for Routine Surveillance Endotracheal Aspirate Cultures in the Treatment of BAL-Confirmed Ventilator-Associated Pneumonia?
Chest, February 1, 2005; 127(2): 425 - 427.
[Full Text] [PDF]

Home page
 ChestHome page
F. Michel, B. Franceschini, P. Berger, J.-M. Arnal, M. Gainnier, J.-M. Sainty, and L. Papazian
Early Antibiotic Treatment for BAL-Confirmed Ventilator-Associated Pneumonia: A Role for Routine Endotracheal Aspirate Cultures
Chest, February 1, 2005; 127(2): 589 - 597.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Rello, C. Lorente, E. Diaz, M. Bodi, C. Boque, A. Sandiumenge, and J. M. Santamaria
Incidence, Etiology, and Outcome of Nosocomial Pneumonia in ICU Patients Requiring Percutaneous Tracheotomy for Mechanical Ventilation
Chest, December 1, 2003; 124(6): 2239 - 2243.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
G. Zanetti, F. Bally, G. Greub, J. Garbino, T. Kinge, D. Lew, J.-A. Romand, J. Bille, D. Aymon, L. Stratchounski, et al.
Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study
Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3442 - 3447.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. G. Wunderink, J. Rello, S. K. Cammarata, R. V. Croos-Dabrera, and M. H. Kollef
Linezolid vs Vancomycin: Analysis of Two Double-Blind Studies of Patients With Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
Chest, November 1, 2003; 124(5): 1789 - 1797.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. E. Ost, C. S. Hall, G. Joseph, C. Ginocchio, S. Condon, E. Kao, M. LaRusso, R. Itzla, and A. M. Fein
Decision Analysis of Antibiotic and Diagnostic Strategies in Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1060 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
R. P. Baughman and M. A. Kerr
Ventilator-Associated Pneumonia Patients who Do Not Reduce Bacteria from the Lungs have a Worse Prognosis
J Intensive Care Med, September 1, 2003; 18(5): 269 - 274.
[Abstract] [PDF]

Home page
 ChestHome page
S. Osmon, D. Warren, S. M. Seiler, W. Shannon, V. J. Fraser, and M. H. Kollef
The Influence of Infection on Hospital Mortality for Patients Requiring > 48 h of Intensive Care
Chest, September 1, 2003; 124(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
R. M. Mehta and M. S. Niederman
Nosocomial Pneumonia in the Intensive Care Unit: Controversies and Dilemmas
J Intensive Care Med, July 1, 2003; 18(4): 175 - 188.
[Abstract] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. A. Karlowsky, M. E. Jones, C. Thornsberry, I. R. Friedland, and D. F. Sahm
Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001
Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1672 - 1680.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Brun-Buisson
Antibiotic Therapy of Ventilator-Associated Pneumonia: In Search of the Magic Bullet
Chest, March 1, 2003; 123(3): 670 - 673.
[Full Text] [PDF]

Home page
 ChestHome page
R. A. Fowler, K. E. Flavin, J. Barr, A. B. Weinacker, J. Parsonnet, and M. K. Gould
Variability in Antibiotic Prescribing Patterns and Outcomes in Patients With Clinically Suspected Ventilator-Associated Pneumonia
Chest, March 1, 2003; 123(3): 835 - 844.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. W. Waterer
The Diagnostic Dilemma in Suspected Ventilator-Associated Pneumonia: One Size Will Never Fit All
Chest, February 1, 2003; 123(2): 335 - 337.
[Full Text] [PDF]

Home page
 ChestHome page
J. Rello, D. A. Ollendorf, G. Oster, M. Vera-Llonch, L. Bellm, R. Redman, and M. H. Kollef
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
Chest, December 1, 2002; 122(6): 2115 - 2121.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Hoffken and M. S. Niederman
Nosocomial Pneumonia: The Importance of a De-escalating Strategy for Antibiotic Treatment of Pneumonia in the ICU
Chest, December 1, 2002; 122(6): 2183 - 2196.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. Lambotte, J.-F. Timsit, M. Garrouste-Orgeas, B. Misset, A. Benali, and J. Carlet
The Significance of Distal Bronchial Samples With Commensals in Ventilator-Associated Pneumonia: Colonizer or Pathogen?
Chest, October 1, 2002; 122(4): 1389 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Leroy, P. Giradie, Y. Yazdanpanah, H. Georges, S. Alfandari, V. Sanders, P. Devos, and G. Beaucaire
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
Eur. Respir. J., August 1, 2002; 20(2): 432 - 439.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. L. Bowton
Cultures and Ventilator-Associated Pneumonia : Not How, But How Many
Chest, August 1, 2002; 122(2): 401 - 402.
[Full Text] [PDF]

Home page
 ChestHome page
M. Iregui, S. Ward, G. Sherman, V. J. Fraser, and M. H. Kollef
Clinical Importance of Delays in the Initiation of Appropriate Antibiotic Treatment for Ventilator-Associated Pneumonia*
Chest, July 1, 2002; 122(1): 262 - 268.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. Chastre and J.-Y. Fagon
Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S Ewig, T Bauer, and A Torres
The pulmonary physician in critical care * 4: Nosocomial pneumonia
Thorax, April 1, 2002; 57(4): 366 - 371.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. Giamarellou
Prescribing guidelines for severe Pseudomonas infections
J. Antimicrob. Chemother., February 1, 2002; 49(2): 229 - 233.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. HAYON, C. FIGLIOLINI, A. COMBES, J.-L. TROUILLET, N. KASSIS, M. C. DOMBRET, C. GIBERT, and J. CHASTRE
Role of Serial Routine Microbiologic Culture Results in the Initial Management of Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 41 - 46.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. E. Marik and J. Varon
Ventilator-Associated Pneumonia : Science and Hocus-Pocus
Chest, September 1, 2001; 120(3): 702 - 704.
[Full Text] [PDF]

Home page
 ChestHome page
J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al.
International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia
Chest, September 1, 2001; 120(3): 955 - 970.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. H. Ibrahim, L. Tracy, C. Hill, V. J. Fraser, and M. H. Kollef
The Occurrence of Ventilator-Associated Pneumonia in a Community Hospital : Risk Factors and Clinical Outcomes
Chest, August 1, 2001; 120(2): 555 - 561.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Ioanas, R. Ferrer, J. Angrill, M. Ferrer, and A. Torres
Microbial investigation in ventilator-associated pneumonia
Eur. Respir. J., April 1, 2001; 17(4): 791 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. BLOT, B. RAYNARD, E. CHACHATY, C. TANCRÈDE, S. ANTOUN, and G. NITENBERG
Value of Gram Stain Examination of Lower Respiratory Tract Secretions for Early Diagnosis of Nosocomial Pneumonia
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1731 - 1737.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
R. S. Morehead and S. J. Pinto
Ventilator-Associated Pneumonia
Arch Intern Med, July 10, 2000; 160(13): 1926 - 1936.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, and M. H. Kollef
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
Chest, July 1, 2000; 118(1): 146 - 155.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. RUIZ, A. TORRES, S. EWIG, M. A. MARCOS, A. ALCÓN, R. LLEDÓ, M. A. ASENJO, and A. MALDONALDO
Noninvasive Versus Invasive Microbial Investigation in Ventilator-associated Pneumonia . Evaluation of Outcome
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 119 - 125.
[Abstract] [Full Text]

Home page
 ChestHome page
E. H. Ibrahim, S. Ward, G. Sherman, and M. H. Kollef
A Comparative Analysis of Patients With Early-Onset vs Late-Onset Nosocomial Pneumonia in the ICU Setting
Chest, May 1, 2000; 117(5): 1434 - 1442.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. S. Niederman
Bronchoscopy in Nonresolving Nosocomial Pneumonia
Chest, April 1, 2000; 117(4_suppl_2): 212S - 218S.
[Full Text] [PDF]

Home page
 ChestHome page
P. E. Marik
Fever in the ICU
Chest, March 1, 2000; 117(3): 855 - 869.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. M. Luna, A. Videla, J. Mattera, C. Vay, A. Famiglietti, P. Vujacich, and M. S. Niederman
Blood Cultures Have Limited Value in Predicting Severity of Illness and as a Diagnostic Tool in Ventilator-Associated Pneumonia
Chest, October 1, 1999; 116(4): 1075 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. RELLO, M. SA-BORGES, H. CORREA, S.-R. LEAL, and J. BARAIBAR
Variations in Etiology of Ventilator-associated Pneumonia across Four Treatment Sites . Implications for Antimicrobial Prescribing Practices
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 608 - 613.
[Abstract] [Full Text]

Home page
 NEJMHome page
M. H. Kollef
The Prevention of Ventilator-Associated Pneumonia
N. Engl. J. Med., February 25, 1999; 340(8): 627 - 634.
[Full Text] [PDF]

Home page
 ChestHome page
M. H. Kollef, G. Sherman, S. Ward, and V. J. Fraser
Inadequate Antimicrobial Treatment of Infections: A Risk Factor for Hospital Mortality Among Critically Ill Patients
Chest, February 1, 1999; 115(2): 462 - 474.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. H. Kollef
Antimicrobial Therapy of Ventilator-Associated Pneumonia : How To Select an Appropriate Drug Regimen
Chest, January 1, 1999; 115(1): 8 - 11.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society 		  ATS Par News